HOME › DRUGS › GALSULFASE
ACTIVE SUBSTANCE / INN

GALSULFASE

Brand name(s): NAGLAZYME, Naglazyme
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Mucopolysaccharidosis VI
BLA125117
ACTIVE SUBSTANCE
Galsulfase
REGULATORS
FDA · EMA
SPONSORS / MAH
BioMarin International Limited, BIOMARIN
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NAGLAZYMEBLA125117BIOMARINPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NaglazymeBioMarin International LimitedAuthorised23/01/2006Mucopolysaccharidosis VI

FULL INTELLIGENCE ON GALSULFASE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →